References
- GirardPMimounGKarpouzasIMontefioreGClinical risk factors for proliferative vitreoretinopathy after retinal detachment surgeryRetina19941454174247899716
- CharterisDGSethiCSLewisGPFisherSKProliferative vitreoretinopathy: developments in adjunctive treatment and retinal pathologyEye (Lond)200216436937412101443
- ColyerMHChunDWBowerKSDickJSWeichelEDPerforating globe injuries during operation Iraqi FreedomOphthalmology2008115112087209318672293
- LaquaHMachemerRGlial cell proliferation in retinal detachment (massive periretinal proliferation)Am J Ophthalmol1975804602618810029
- MachemerRLaquaHPigment epithelium proliferation in retinal detachment (massive periretinal proliferation)Am J Ophthalmol1975801123808131
- CampochiaroPAJerdanJAGlaserBMCardinAMichelsRGVitreous aspirates from patients with proliferative vitreoretinopathy stimulate retinal pigment epithelial cell migrationArch Ophthalmol19851039140314054038135
- GlaserBMCardinABiscoeBProliferative vitreoretinopathy. The mechanism of development of vitreoretinal tractionOphthalmology19879443273323587912
- PeymanGASmithRTCharlesHInjection of fluorosilicone oil and pars plana vitrectomy for complex retinal detachmentCan J Ophthalmol19872252762783664355
- BatmanCCekicOEffects of the long-term use of perfluoroperhydrophenanthrene on the retinaOphthalmic Surg Lasers19982921441469507258
- ViebahnMBuettnerHPerfluorophenanthrene unsuitable for postoperative retinal tamponadeAm J Ophthalmol199411811241268023869
- GerdingHKolckAPerfluorohexyloctane as internal tamponade in patients with complicated retinal detachment. Results after 6 monthsOphthalmologe20041013255262 German15007606
- RoiderJHoeraufHKobuchKGabelVPClinical findings on the use of long-term heavy tamponades (semifluorinated alkanes and their oligomers) in complicated retinal detachment surgeryGraefes Arch Clin Exp Ophthalmol20022401296597112483317
- VoteBWheenLCluroeATeohHMcGeorgeAFurther evidence for proinflammatory nature of perfluorohexyloctane in the eyeClin Experiment Ophthalmol200331540841414516428
- MertensSBednarzJEngelmannKEvidence of toxic side effects of perfluorohexyloctane after vitreoretinal surgery as well as in previously established in vitro models with ocular cell typesGraefes Arch Clin Exp Ophthalmol20022401298999512483321
- SandnerDHerbrigEEngelmannKHigh-density silicone oil (Densiron) as a primary intraocular tamponade: 12-month follow upGraefes Arch Clin Exp Ophthalmol200724581097110517219121
- TheelenTTilanusMAKleveringBJIntraocular inflammation following endotamponade with high-density silicone oilGraefes Arch Clin Exp Ophthalmol2004242761762015029505
- DruryBBourkeRDShort-term intraocular tamponade with perfluorocarbon heavy liquidBr J Ophthalmol201195569469820934993
- RushRShethSSurkaSHoIGregory-RobertsJPostoperative perfluoro-n-octane tamponade for primary retinal detachment repairRetina20123261114112021968506
- BarthelmesDAlexanderSMitchellPChandraJHybrid 20/23-Gauge pars plana vitrectomy for retained lens fragments after cataract surgeryRetina20123291749175522466486
- FanninLASchiffmanJCBudenzDLRisk factors for hypotony maculopathyOphthalmology200311061185119112799246
- UgaharyLCGanterisEVeckeneerMTopical ibopamine in the treatment of chronic ocular hypotony attributable to vitreoretinal surgery, uveitis, or penetrating traumaAm J Ophthalmol2006141357157316490513
- QuiramPAGonzalesCRHuWOutcomes of vitrectomy with inferior retinectomy in patients with recurrent rhegmatogenous retinal detachments and proliferative vitreoretinopathyOphthalmology2006113112041204716952397
- RofailMLeeLRPerfluoro-n-octane as a postoperative vitreoretinal tamponade in the management of giant retinal tearsRetina200525789790116205570
- GerdingHHeavy internal tamponades and risk of hypotonyEye (Lond)2010246111419942936
- RomanoMRGroenwaldCDasRStapplerTWongDHeimannHRemoval of Densiron-68 with a 23-gauge transconjunctival vitrectomy systemEye (Lond)200923371571719151654